Saphris

QUICK REFERENCE TO PSYCHOTROPIC MEDICATIONS

asenapine Saphris 10-20 mg low low + + 1-2 mg lurasidone Latuda 40-80 mg mid mid + + 10 mg aripiprazole Abilify 15-30mg low low + + 2 mg Consumer’s Guide to Psychiatric Drugs (2009) Preston, O’Neal, Talaga Child and Adolescent Psychopharmacology Made Simple (2010) Preston, O’Neal, Talaga 1Usual daily oral dosage

  Parish, Psychotropic

QUICK REFERENCE TO PSYCHOTROPIC MEDICATIONS

asenapine Saphris 10-20 mg low low + + 1-2 mg lurasidone Latuda 40-80 mg mid mid + + 10 mg aripiprazole Abilify 15-30mg low low + + 2 mg Consumer’s Guide to Psychiatric Drugs (2009) Preston, O’Neal, Talaga Child and Adolescent Psychopharmacology Made Simple (2010) Preston, O’Neal, Talaga 1Usual daily oral dosage

  Reference, Parish, Quick, Psychotropic, Quick reference to psychotropic

DOSING AND TITRATION OF COMMONLY USED …

Saphris (asenapine SL tabs) Schizophrenia Acute: 5mg twice daily Maintenance: 5mg twice daily Acute: 5mg twice daily; max 20mg/day Maintenance: 10mg twice daily; max 20mg/day Maintenance: Increase to max 10mg twice daily after 1 week Seroquel (quetiapine fumarate tabs) Schizophrenia 25mg twice daily on day 1; increase by 25–50mg 2–3

  Used, Parish, Commonly, Titrations, Titration of commonly used

Medications To Be Avoided Or Used With Caution in ...

Saphris® Block dopamine receptors, but dissociate from the recep-tor more quickly than typical antipsychotics. They also tend to block serotonin receptors in addition to dopamine recep-tors. The result is less parkin-sonism than that caused by the typical antipsychotics. Antiemetics (used to treat nausea or vomiting) Chlorpromazine Droperidol

  With, Used, Parish, Auction, Avoided, Avoided or used with caution

LIST OF DIFFERENT GROUPS OF MEDICATIONS

(Saphris) is a 5 ‐HT2A and D2receptor antagonist under development for the treatment of schizophrenia and acute mania associated with bipolar disorder. • Paliperidone (Invega) ‐ Derivative of risperidone that was approved in 2006. • Iloperidone (Fanapt) ‐ Approved by the FDA

  Parish

Aging Brain Care - UCLA GWEP

Asenapine Saphris™ Atenolol Tenormin™ Bupropion Wellbutrin™, Zyban™ Captopril Capoten™ Cetirizine Zyrtec™ Chlorthalidone Diuril™, Hygroton™ Cimetidine Tagamet™ Clidinium Librax™ Clorazepate Tranxene™ Codeine Contin™ Colchicine Colcrys™ Desloratadine Clarinex™ Diazepam Valium™ Digoxin Lanoxin™ Dipyridamole ...

  Care, Parish, Aging, Brain, Aging brain care

GeneSight Psychotropic

asenapine (Saphris®) cariprazine (Vraylar®) lumateperone (Caplyta®) lurasidone (Latuda®) paliperidone (Invega®) thiothixene (Navane®) ziprasidone (Geodon®) fluphenazine (Prolixin®) 1 olanzapine (Zyprexa ®) 1 quetiapine (Seroquel ®) 1 clozapine (Clozaril®) ®1,8 haloperidol (Haldol®) 1,8 chlorpromazine (Thorazine®) 1,6 aripiprazole ...

  Parish, Psychotropic, Genesight psychotropic, Genesight

Information Sheet for Psychotropic Medications

Sep 04, 2015 · o Saphris (Asenapine) o Latuda (Lurasidone) * Abilify, Seroquel, and lozapine come with “lack ox Warnings” by the Food and Drug Administration . This means the medication can cause serious undesirable effects (such as a fatal, life-threatening or permanently disabling adverse reaction) to the potential benefit from the drug;

  Parish

Medications Approved by the FDA for Bipolar Disorder

Medication Brand Name Common side effects May interact with Aripiprazole Abilify® Insomnia Nausea Restlessness Tiredness Antidepressants such as Prozac or Paxil

Minimum Laboratory Monitoring For Psychotropic Medications

White Blood Cell Count (WBC) w/ Absolute Neutrophil Count (ANC) Weekly for 1 st 6 months (if values within normal limits), then every 2 wks. for

Second Generation Antipsychotic Sheet

3—©2014‐2017 Magellan Health, Inc. v Leucht S., Komossa K, Rummel-Kluge C, et al. (2009). Meta-Analysis of Head-to Head Comparisons of Second Generation Antipsychotics in the Treatment of Schizophrenia.